Heartburn Meds Use May Lead to Brain Function Loss, Bacterial Infection

Taking proton-pump inhibitors (PPIs) to treat heartburn and acid reflux may cause loss of brain function and a bacterial infection in people with cirrhosis of the liver.

Researchers in Denmark followed 895 patients with either cirrhosis or a condition known as ascites, which is fluid buildup in the abdomen. The original purpose of the study was to examine the effectiveness of a treatment for ascites. A total of 52% of the patients enrolled used a PPI at some point during the trial.

Those who had taken a PPI had a 31% 1-year cumulative risk for hepatic encephalopathy (HE), a loss of brain function when the liver has trouble excreting toxins out of the bloodstream, the researchers reported in the journal Hepatology. The risk for those who did not take a PPI was 25%.

“The findings that PPI use is a risk factor for [spontaneous bacterial peritonitis (SBP)] and that SBP is a risk factor for HE do provide support for the hypothesis that PPIs contribute to the development of HE by promoting translocation of gut bacteria,” the researchers wrote. SBP is a bacterial infection.

PPIs were developed to reduce the production of gastric acid in the gut, as well as increase the pH in the stomach. However, by doing so, they can also cause gut bacteria to multiply and enter the blood and lymph nodes. This can then lead to SBP and hepatic encephalopathy.

The researchers conclude that doctors should be cautious when prescribing PPIs to those with cirrhosis or possible cirrhosis.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement